ArticleInternal medicine (Tokyo, Japan)2019

An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients.

Satoshi Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.